51 results on '"Suaya, Jose"'
Search Results
2. Invasive pneumococcal disease in Canada 2010–2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines
3. Economic evaluation of dengue prevention
4. Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009‒2017
5. One-Year Quality of Life Post–Pneumonia Diagnosis in Japanese Adults
6. Diabetes mellitus as a vaccine-effect modifier: a review
7. Upper respiratory tract colonization withStreptococcus pneumoniaein adults
8. 2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
9. 2728. Proportion of Invasive Pneumococcal Disease Potentially Covered by Current and Next-Generation of Higher-Valency Pneumococcal Conjugate Vaccines in Canada, 2010–2016
10. 1442. Pneumonia Hospitalizations Averted With 13-Valent Pneumococcal Conjugate Vaccination of Adults Aged 18–64 Years With Diabetes in the United States
11. 1440. Potential Impact of Routine Use of 13-Valent Pneumococcal Conjugate Vaccine on Hospitalizations for Pneumonia among Older Adults in Canada
12. 1444. Trends in Antimicrobial Non-susceptibility of PCV13-Type Streptococcus pneumoniae Pneumonia in Adults in the United States During 2009–2017
13. 1446. Correlation Between Adult Invasive and Noninvasive Streptococcus pneumoniae Disease in 13-Valent Pneumococcal Conjugate Vaccine Serotypes in the United States
14. 1453. Ninety-One Day Quality of Life Post-Pneumonia Diagnosis in Adult Patients in Japan
15. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
16. Acute Hospitalizations for Pneumonia in Adults in the United States in 2014
17. Yearly Trends of Antimicrobial Non-susceptibility among Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients in the United States (2009–2015)
18. spaTyping and Multilocus Sequence Typing Show Comparable Performance in a Macroepidemiologic Study ofStaphylococcus aureusin the United States
19. Vaccine-Type Pneumococcal Disease (IPD) and Patterns of Penicillin and Cefotaxime Non-susceptibility Following Routine Use of 13-Valent Conjugate Pneumococcal Infant Vaccination in the United States
20. Invasive Pneumococcal Disease (IPD), Antibiotic Use, and Patterns of Penicillin and Cefotaxime Non-susceptibility Following Routine Use of 13-Valent Conjugate Pneumococcal Infant Vaccination in the United States
21. Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States
22. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010
23. Postoperative Staphylococcus aureus Infections in Medicare Beneficiaries
24. State-by-State Variations in Cardiac Rehabilitation Participation Are Associated With Educational Attainment, Income, and Program Availability
25. Incidence and cost of hospitalizations associated with Staphylococcus aureusskin and soft tissue infections in the United States from 2001 through 2009
26. Smoking Cessation and Attempted Cessation among Adults in the United States
27. Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
28. Incidence and Cost of Pneumonia in Older Adults with COPD in the United States
29. The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers
30. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
31. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus
32. Skin and Soft Tissue Infections and Associated Complications among Commercially Insured Patients Aged 0–64 Years with and without Diabetes in the U.S.
33. Molecular Characterization of Staphylococcus aureus in the United States 2004–2008 Reveals the Rapid Expansion of USA300 Among Inpatients and Outpatients
34. Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
35. Incidence and Cost of Pneumonia in Medicare Beneficiaries
36. Trends and Characteristics of Culture-Confirmed Staphylococcus aureus Infections in a Large U.S. Integrated Health Care Organization
37. Prevalence and Sequence Variation of Panton-Valentine Leukocidin in Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains in the United States
38. Quality of Life among Adults with Confirmed Dengue in Brazil
39. Increasing Role of Staphylococcus aureus and Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in the United States: A 10-Year Trend of Replacement and Expansion
40. Clinical Benefits of the Boston Ocular Surface Prosthesis
41. Economic Appraisal of the Boston Ocular Surface Prosthesis
42. Cardiac Rehabilitation and Survival in Older Coronary Patients
43. Cost of Dengue Cases in Eight Countries in the Americas and Asia: A Prospective Study
44. System-Level Factors and Use of Cardiac Rehabilitation
45. Clinical Characteristics and National Economic Cost of the 2005 Dengue Epidemic in Panama
46. Quality of Life of Dengue Patients
47. Use of Cardiac Rehabilitation by Medicare Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery
48. Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti
49. The burden of dengue infection
50. Overcoming Language Barriers in Health Care: Costs and Benefits of Interpreter Services
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.